BackFate Therapeutics Overview
Fate Therapeutics Inc

Fate Therapeutics Target Price

Where could FATE trade next? Consensus target price: $5.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.72

Average Target Price

$5.50102.2% upside

2 analysts in the last 4 months

High: $7 | Low: $4

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-08H.C. WainwrightDebjit Chattopadhyay$7157.4% upsideOpen
2026-05-19Jefferies$447.1% upsideOpen
2025-03-06Stifel Nicolaus$310.3% upsideOpen
2024-11-13BMO CapitalEtzer Darout$583.8% upsideOpen
2024-08-14Stifel NicolausBenjamin Burnett$583.8% upsideOpen
2024-06-17Piper SandlerEdward Tenthoff$6120.6% upsideOpen
2024-05-16H.C. WainwrightDebjit Chattopadhyay$583.8% upsideOpen
2024-05-10Piper SandlerEdward Tenthoff$447.1% upsideOpen
2024-05-10BMO CapitalEtzer Darout$6120.6% upsideOpen
2024-05-10Canaccord GenuityBill Maughan$9230.9% upsideOpen
2023-01-09Goldman Sachs$447.1% upsideOpen
2023-01-06Morgan Stanley$8194.1% upsideOpen
2023-01-06Piper Sandler$12341.2% upsideOpen
2023-01-06BMO Capital$7157.4% upsideOpen
2023-01-05Truist FinancialRobyn Karnauskas$7157.4% upsideOpen
2022-12-15Goldman SachsAndrea Tan$10267.6% upsideOpen
2022-12-13Truist Financial$461591.2% upsideOpen
2021-12-13OppenheimerMatthew Biegler$1354863.2% upsideOpen
2021-11-08CitigroupYigal Nochomovitz$873098.5% upsideOpen
2021-11-05Roth CapitalAnthony Butler$602105.9% upsideOpen
2021-10-25JefferiesMichael Yee$1455230.9% upsideOpen
2021-08-20Piper SandlerEdward Tenthoff$1134054.4% upsideOpen

Fate Therapeutics (FATE) FAQ

Fate Therapeutics (FATE) currently reports a target price of $5.5. Use the charts on this page to explore Fate Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Fate Therapeutics is $5.5, about 102.2% upside from the current share price of $2.72. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $5.5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fate Therapeutics, and consider following FATE for alerts when major investors trade the stock.

Fate Therapeutics is classified in the Healthcare sector. On target price, it currently shows $5.5. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FATE with unrelated industries.